Our latest AMJ Rheumatology Journal is now live with ACR 2025 coverage. Discover the shift toward earlier, mechanism-based treatments that reduce steroid dependence and protect long-term organ health. See how CAR-T therapy is evolving from cancer care to potentially resetting the immune system in refractory lupus. Plus, explore an unexpected vasculitis case that started with blue toes.
AMJ’s Latest Rheumatology Journal
9 Dec 2025
Rheumatology
Rate this content's potential impact on patient outcomes
Average rating / 5. Vote count:
No votes so far! Be the first to rate this content.





